Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin.

MLA

Stutz, Lina, et al. “Low Incidence of Hepatic Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Adults Undergoing Allogenic Stem Cell Transplantation with Prophylactic Ursodiol and Low-Dose Heparin.” Bone Marrow Transplantation, vol. 57, no. 3, Mar. 2022, pp. 391–98. EBSCOhost, https://doi.org/10.1038/s41409-021-01546-w.

APA

Stutz, L., Halter, J. P., Heim, D., Passweg, J. R., & Medinger, M. (2022). Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin. Bone Marrow Transplantation, 57(3), 391–398. https://doi.org/10.1038/s41409-021-01546-w

Chicago

Stutz, Lina, Jörg P Halter, Dominik Heim, Jakob R Passweg, and Michael Medinger. 2022. “Low Incidence of Hepatic Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Adults Undergoing Allogenic Stem Cell Transplantation with Prophylactic Ursodiol and Low-Dose Heparin.” Bone Marrow Transplantation 57 (3): 391–98. doi:10.1038/s41409-021-01546-w.